Marsal Sanches1, Gabriela D Colpo2, Valeria A Cuellar1, Taya Bockmann1, Deevakar Rogith3, Jair C Soares1, Antonio L Teixeira2. 1. Department of Psychiatry and Behavioral Sciences, UT Center of Excellence on Mood Disorders, The University of Texas Health Science Center at Houston, Houston, TX, United States. 2. Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States. 3. School of Biomedical Informatics, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Abstract
BACKGROUND: Dysfunctions in the renin-angiotensin system (RAS) seem to be involved in the pathophysiology of several mental illness, including schizophrenia and mood disorders. We carried out a cross-sectional study assessing the levels of RAS-related molecules among bipolar disorder (BD) patients compared to healthy controls. METHODS: our sample consisted of 30 outpatients with BD type 1 (10 males, 20 females, age = 35.53 ± 10.59 years, 14 euthymic, 16 experiencing mood episodes) and 30 healthy controls (10 males, 20 females, age = 34.83 ± 11.49 years). Plasma levels of angiotensin-converting enzyme (ACE), angiotensin-converting enzyme 2 (ACE2), angiotensin-II (Ang II), and angiotensin (1-7) [Ang-(1-7)] were determined by ELISA. RESULTS: BD patients experiencing ongoing mood episodes had significantly lower ACE levels compared to controls (median: 459.00 vs. 514.10, p < 0.05). There was no association between the levels of these biomarkers and clinical parameters. CONCLUSION: Our findings support the involvement of RAS dysfunction in the pathophysiology of BD. Considering the potential therapeutic implications linked to a better understanding of the role of RAS dysfunction in BD, studies allowing a better characterization of RAS-related molecules level and activity across different mood states are of high interest.
BACKGROUND: Dysfunctions in the renin-angiotensin system (RAS) seem to be involved in the pathophysiology of several mental illness, including schizophrenia and mood disorders. We carried out a cross-sectional study assessing the levels of RAS-related molecules among bipolar disorder (BD) patients compared to healthy controls. METHODS: our sample consisted of 30 outpatients with BD type 1 (10 males, 20 females, age = 35.53 ± 10.59 years, 14 euthymic, 16 experiencing mood episodes) and 30 healthy controls (10 males, 20 females, age = 34.83 ± 11.49 years). Plasma levels of angiotensin-converting enzyme (ACE), angiotensin-converting enzyme 2 (ACE2), angiotensin-II (Ang II), and angiotensin (1-7) [Ang-(1-7)] were determined by ELISA. RESULTS: BD patients experiencing ongoing mood episodes had significantly lower ACE levels compared to controls (median: 459.00 vs. 514.10, p < 0.05). There was no association between the levels of these biomarkers and clinical parameters. CONCLUSION: Our findings support the involvement of RAS dysfunction in the pathophysiology of BD. Considering the potential therapeutic implications linked to a better understanding of the role of RAS dysfunction in BD, studies allowing a better characterization of RAS-related molecules level and activity across different mood states are of high interest.
Authors: Ana Isabelle de Góis Queiroz; Camila Dantas Medeiros; Bruna Mara Machado Ribeiro; David Freitas de Lucena; Danielle Silveira Macêdo Journal: Med Hypotheses Date: 2012-12-20 Impact factor: 1.538
Authors: Viktoria Stelzhammer; Frieder Haenisch; Man K Chan; Jason D Cooper; Johann Steiner; Hannah Steeb; Daniel Martins-de-Souza; Hassan Rahmoune; Paul C Guest; Sabine Bahn Journal: Int J Neuropsychopharmacol Date: 2014-06-05 Impact factor: 5.176
Authors: M Ito; M I Oliverio; P J Mannon; C F Best; N Maeda; O Smithies; T M Coffman Journal: Proc Natl Acad Sci U S A Date: 1995-04-11 Impact factor: 11.205
Authors: Natalia Pessoa Rocha; Ana Cristina Simoes E Silva; Thiago Ruiz Rodrigues Prestes; Victor Feracin; Caroline Amaral Machado; Rodrigo Novaes Ferreira; Antonio Lucio Teixeira; Aline Silva de Miranda Journal: Curr Med Chem Date: 2018 Impact factor: 4.530
Authors: Henry Daniell; Smruti K Nair; Yao Shi; Ping Wang; Kathleen T Montone; Pamela A Shaw; Grace H Choi; Danyal Ghani; JoEllen Weaver; Daniel J Rader; Kenneth B Margulies; Ronald G Collman; Krzysztof Laudanski; Katharine J Bar Journal: Mol Ther Methods Clin Dev Date: 2022-07-06 Impact factor: 5.849